• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核性心包炎的免疫发病机制。

The immunopathogenesis of tuberculous pericarditis.

机构信息

National Heart & Lung Institute, Imperial College London, Guy Scadding Building, Cale Street, London, SW3 6LY, United Kingdom; Department of Medicine, University of Cape Town, Observatory 7925, South Africa.

Department of Medicine, University of Cape Town, Observatory 7925, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa.

出版信息

Microbes Infect. 2020 May-Jun;22(4-5):172-181. doi: 10.1016/j.micinf.2020.02.001. Epub 2020 Feb 21.

DOI:10.1016/j.micinf.2020.02.001
PMID:32092538
Abstract

Tuberculous pericarditis is a severe form of extrapulmonary tuberculosis and is the commonest cause of pericardial effusion in high incidence settings. Mortality ranges between 8 and 34%, and it is the leading cause of pericardial constriction in Africa and Asia. Current understanding of the disease is based on models derived from studies performed in the 1940-50s. This review summarises recent advances in the histology, microbiology and immunology of tuberculous pericarditis, with special focus on the effect of Human Immunodeficiency Virus (HIV) and the determinants of constriction.

摘要

结核性心包炎是一种严重的肺外结核形式,是高发地区心包积液的最常见原因。死亡率在 8%至 34%之间,是非洲和亚洲心包缩窄的主要原因。目前对该病的认识是基于上世纪 40 年代至 50 年代进行的研究中得出的模型。本综述总结了结核性心包炎在组织学、微生物学和免疫学方面的最新进展,特别关注了人类免疫缺陷病毒(HIV)的影响和缩窄的决定因素。

相似文献

1
The immunopathogenesis of tuberculous pericarditis.结核性心包炎的免疫发病机制。
Microbes Infect. 2020 May-Jun;22(4-5):172-181. doi: 10.1016/j.micinf.2020.02.001. Epub 2020 Feb 21.
2
A modern approach to tuberculous pericarditis.结核性心包炎的现代治疗方法。
Prog Cardiovasc Dis. 2007 Nov-Dec;50(3):218-36. doi: 10.1016/j.pcad.2007.03.002.
3
Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions.对比非结核性心包积液,对HIV阳性和HIV阴性患者结核性心包积液的免疫学特征进行表征。
Tuberculosis (Edinb). 2006 Mar;86(2):125-33. doi: 10.1016/j.tube.2005.08.018. Epub 2005 Dec 19.
4
Tuberculous pericarditis: optimal diagnosis and management.结核性心包炎:最佳诊断与管理
Clin Infect Dis. 2001 Oct 1;33(7):954-61. doi: 10.1086/322621. Epub 2001 Aug 22.
5
T cell-based assay of pericardial fluid mononuclear cells for the diagnosis of tuberculous pericardial effusion.基于T细胞的心包积液单核细胞检测用于诊断结核性心包积液
J Am Coll Cardiol. 2014 Nov 4;64(18):1966-8. doi: 10.1016/j.jacc.2014.07.983. Epub 2014 Oct 27.
6
Predictive factors for unfavorable outcomes of tuberculous pericarditis in human immunodeficiency virus-uninfected patients in an intermediate tuberculosis burden country.在一个结核病负担中等的国家,未感染人类免疫缺陷病毒的患者患结核性心包炎不良预后的预测因素。
BMC Infect Dis. 2016 Nov 29;16(1):719. doi: 10.1186/s12879-016-2062-5.
7
Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.酶联免疫斑点试验(ELISPOT)检测心包积液在疑似结核性心包炎病例中的临床应用价值
Infection. 2008 Dec;36(6):601-4. doi: 10.1007/s15010-008-7402-y. Epub 2008 Oct 14.
8
Tuberculous effusive-constrictive pericarditis.结核性渗出缩窄性心包炎
Cardiovasc J Afr. 2008 Jul-Aug;19(4):200-1.
9
A prospective investigation into the effect of colchicine on tuberculous pericarditis.秋水仙碱对结核性心包炎影响的前瞻性研究。
Cardiovasc J Afr. 2016 Nov/Dec;27(6):350-355. doi: 10.5830/CVJA-2016-035.
10
Porcelain heart: severely calcified pericardium due to Mycobacterium tuberculosis.瓷心:由结核分枝杆菌引起的严重钙化心包。
Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):229. doi: 10.1177/0218492312468117. Epub 2013 Jul 11.

引用本文的文献

1
The Use of Corticosteroids in Patients With Pleural and Pericardial Tuberculosis.皮质类固醇在胸膜和心包结核患者中的应用
J Community Hosp Intern Med Perspect. 2025 Mar 7;15(2):35-47. doi: 10.55729/2000-9666.1453. eCollection 2025.
2
Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa.非洲南部接受治疗的结核病患者的心血管受累情况
JACC Adv. 2024 Dec 5;4(1):101427. doi: 10.1016/j.jacadv.2024.101427. eCollection 2025 Jan.
3
Tuberculous Pericarditis in an Immunocompromised Patient: A Case Report.
免疫功能低下患者的结核性心包炎:一例报告
Cureus. 2024 Oct 15;16(10):e71507. doi: 10.7759/cureus.71507. eCollection 2024 Oct.
4
Prevalence and patterns of echocardiographic abnormalities among people living with HIV on anti-retroviral therapy in Kumasi, Ghana.加纳库马西接受抗逆转录病毒治疗的艾滋病毒感染者中心脏超声异常的流行情况和模式。
BMC Cardiovasc Disord. 2024 Aug 27;24(1):453. doi: 10.1186/s12872-024-04117-1.
5
Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection.基质细胞蛋白水平在血液中的动态变化可预测人类免疫缺陷病毒-结核病合并感染患者的恢复情况。
Viruses. 2024 Apr 24;16(5):664. doi: 10.3390/v16050664.
6
Comparison of the frequency and phenotypic profile of -specific CD4 T cells between the site of disease and blood in pericardial tuberculosis.比较心包结核疾病部位和血液中 -特异性 CD4 T 细胞的频率和表型特征。
Front Immunol. 2022 Nov 11;13:1009016. doi: 10.3389/fimmu.2022.1009016. eCollection 2022.
7
Tuberculous pericarditis-a silent and challenging disease: A case report.结核性心包炎——一种隐匿且具有挑战性的疾病:病例报告
World J Clin Cases. 2022 Feb 26;10(6):1869-1875. doi: 10.12998/wjcc.v10.i6.1869.
8
Early Testing and Prompt Initiation of Proper Treatment: a Clever Strategy to Fight with Tuberculosis Pericarditis.早期检测并及时开始恰当治疗:对抗结核性心包炎的明智策略。
Korean Circ J. 2020 Jul;50(7):610-612. doi: 10.4070/kcj.2020.0179.